文献速递类风湿关节炎

抑郁作为类风湿关节炎发病危险因素:一项基于人群的队列研究

Depression as a risk factor for the development of rheumatoid arthritis: a population-based cohort study.
PubMed 文献 · RMD Open · 2018-07-11

基于健康改善网络(THIN)数据库1986至2012年的回顾性队列研究,纳入403932例重性抑郁障碍(MDD)患者与5339399例对照。Cox比例风险模型显示,MDD患者发生类风湿关节炎(RA)的风险升高31%(HR=1.31,95%CI 1.25至1.36,p<0.0001),调整全部协变量后风险仍显著升高(HR=1.38,95%CI 1.31至1.46,p<0.0001)。抗抑郁药使用对MDD与RA的关联具有保护性混杂效应。

要点

  • MDD患者发生RA的风险较无MDD者升高31%(HR=1.31,95%CI 1.25至1.36,p<0.0001)。
  • 调整年龄、性别、合并症、吸烟、体重指数及抗抑郁药使用后,风险仍显著升高(HR=1.38,95%CI 1.31至1.46,p<0.0001)。
  • 抗抑郁药使用对MDD与RA的关联具有保护性混杂效应。

核心结论

  • MDD使发生RA的风险升高38%,抗抑郁药可能降低这些患者的该风险。
  • 未来研究有必要确认MDD影响RA发病机制的内在机制。

研究设计与样本

  • 采用健康改善网络(THIN)数据库1986至2012年数据开展的回顾性队列研究。
  • 纳入403932例MDD患者与5339399例无MDD的对照者,观察至发生RA或删失。
  • 采用Cox比例风险模型评估MDD患者发生RA的风险,并调整年龄、性别、医学合并症、吸烟、体重指数及抗抑郁药使用。

主要发现

  • 未调整模型中,MDD患者发生RA的风险升高31%(HR=1.31,95%CI 1.25至1.36,p<0.0001)。
  • 调整全部协变量后,MDD患者发生RA的风险仍显著升高(HR=1.38,95%CI 1.31至1.46,p<0.0001)。
  • 抗抑郁药使用对MDD与RA的关联表现出保护性混杂效应。

局限性

  • 未来研究有必要确认MDD影响RA发病机制的内在机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Major depressive disorder (MDD) is associated with increased levels of systemic proinflammatory cytokines, including tumour necrosis factor alpha. As these cytokines are pathogenic in autoimmune diseases such as rheumatoid arthritis (RA), our aim was to explore on a population-level whether MDD increases the risk of developing RA. METHODS: A retrospective cohort study was conducted using The Health Improvement Network (THIN) database (from 1986 to 2012). Observation time was recorded for both the MDD and referent cohorts until patients developed RA or were censored. Cox proportional hazards models were used to determine the risk of developing RA among patients with MDD, accounting for age, sex, medical comorbidities, smoking, body mass index and antidepressant use. RESULTS: A cohort of 403 932 patients with MDD and a referent cohort of 5 339 399 patients without MDD were identified in THIN. Cox proportional hazards models revealed a 31% increased risk of developing RA among those with MDD in an unadjusted model (HR=1.31, 95% CI 1.25 to 1.36, p<0.0001). When adjusting for all covariates, the risk remained significantly increased among those with MDD (HR=1.38, 95% CI 1.31 to 1.46, p<0.0001). Antidepressant use demonstrated a confounding effect that was protective on the association between MDD and RA. CONCLUSION: MDD increased the risk of developing RA by 38%, and antidepressants may decrease this risk in these patients. Future research is necessary to confirm the underlying mechanism of MDD on the pathogenesis of RA.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Vallerand IA, Lewinson RT, Frolkis AD, et al. Depression as a risk factor for the development of rheumatoid arthritis: a population-based cohort study. RMD Open. 2018. PMID: 30018804. doi:10.1136/rmdopen-2018-000670

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。